Wednesday, June 7, 2023
HomeHealthcare Device SecurityFDA issues guidance on predetermined change control plans for AI/ML-enabled device software...

FDA issues guidance on predetermined change control plans for AI/ML-enabled device software functions – Commentary

IntroductionIn more detailDescription of modificationModification protocolImpact assessmentAuthorised PCCPsCommentIntroductionOn 3 April 2023, the Food and Drug Administration (FDA) issued a draft guidance for industry,(1) for manufacturers whose medical devices use machine learning (ML)…

Source: www.lexology.comRead more

Must Read

HIMSS23 Europe: Promoting patient trust in health data sharing

Patient involvement is vital in creating the new digital world of healthcare, but often citizens often feel fear and distrust about the use of...